BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 90 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $376,000 | -25.2% | 7,117 | -13.3% | 0.00% | 0.0% |
| Q2 2020 | $503,000 | +16.4% | 8,212 | +7.6% | 0.00% | 0.0% |
| Q1 2020 | $432,000 | -0.7% | 7,634 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $435,000 | +7.4% | 7,634 | +0.8% | 0.00% | 0.0% |
| Q3 2019 | $405,000 | -11.4% | 7,575 | -1.0% | 0.00% | 0.0% |
| Q2 2019 | $457,000 | +0.4% | 7,650 | +4.7% | 0.00% | 0.0% |
| Q1 2019 | $455,000 | -0.2% | 7,306 | -3.0% | 0.00% | 0.0% |
| Q4 2018 | $456,000 | +54.6% | 7,530 | +49.5% | 0.00% | 0.0% |
| Q3 2018 | $295,000 | +23.4% | 5,038 | -5.6% | 0.00% | – |
| Q2 2018 | $239,000 | +8.1% | 5,338 | +7.1% | 0.00% | – |
| Q1 2018 | $221,000 | -0.9% | 4,983 | -3.4% | 0.00% | – |
| Q4 2017 | $223,000 | -29.2% | 5,158 | -23.9% | 0.00% | -100.0% |
| Q3 2017 | $315,000 | -4.5% | 6,777 | +1.6% | 0.00% | 0.0% |
| Q2 2017 | $330,000 | -2.9% | 6,667 | +7.5% | 0.00% | 0.0% |
| Q1 2017 | $340,000 | +5.6% | 6,201 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $322,000 | +32.0% | 5,789 | +8.2% | 0.00% | 0.0% |
| Q3 2016 | $244,000 | +19.0% | 5,350 | +4.3% | 0.00% | 0.0% |
| Q2 2016 | $205,000 | -0.5% | 5,130 | +6.8% | 0.00% | 0.0% |
| Q4 2015 | $206,000 | – | 4,804 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 73,649 | $3,646,000 | 2.32% |
| Stonepine Capital Management, LLC | 59,878 | $2,965,000 | 1.60% |
| NORTHPOINTE CAPITAL LLC | 109,644 | $5,428,000 | 0.57% |
| Elk Creek Partners, LLC | 145,406 | $7,199,000 | 0.47% |
| TFS CAPITAL LLC | 18,208 | $901,000 | 0.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 161,671 | $8,004,000 | 0.35% |
| Ativo Capital Management LLC | 19,592 | $970,000 | 0.26% |
| Matarin Capital Management, LLC | 57,034 | $2,823,753,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 16,505 | $817,000 | 0.24% |
| Stanley-Laman Group, Ltd. | 12,546 | $621,000 | 0.17% |